Summary |
|
1 | (1) |
|
|
1 | (3) |
|
Identifying the Pathogens to Study |
|
|
2 | (1) |
|
Development of Conclusions |
|
|
3 | (1) |
|
|
4 | (3) |
|
Sufficient Evidence of a Causal Relationship |
|
|
4 | (1) |
|
Sufficient Evidence of an Association |
|
|
5 | (1) |
|
Limited or Suggestive Evidence of an Association |
|
|
6 | (1) |
|
Inadequate or Insufficient Evidence to Determine Whether an Association Exists |
|
|
6 | (1) |
|
Limited or Suggestive Evidence of No Association |
|
|
7 | (1) |
|
Department of Defense Policies on Tuberculin Skin Testing and Predeployment and Postdeployment Serum Collection |
|
|
7 | (2) |
|
|
9 | (10) |
|
Identifying the Infectious Diseases to Study |
|
|
13 | (2) |
|
The Committee's Approach to Its Charge |
|
|
15 | (1) |
|
Organization of the Report |
|
|
16 | (1) |
|
|
16 | (3) |
|
|
19 | (16) |
|
Identifying the Infectious Diseases to Study |
|
|
19 | (10) |
|
|
19 | (1) |
|
Infectious Diseases Endemic to Southwest and South-Central Asia That Have Long-Term Adverse Health Outcomes |
|
|
20 | (4) |
|
Direct Attribution to Military Service in Southwest and South-Central Asia |
|
|
24 | (3) |
|
Timing of Appearance of Long-Term Adverse Health Outcomes |
|
|
27 | (1) |
|
The Infectious Diseases to Be Studied for Strength of Association with Long-Term Adverse Health Outcomes |
|
|
27 | (1) |
|
Comments on Diseases and Agents of Special Interest to Gulf War, OEF, and OIF Veterans |
|
|
28 | (1) |
|
Review and Evaluation of the Literature |
|
|
29 | (1) |
|
Selection of the Literature |
|
|
29 | (1) |
|
|
29 | (1) |
|
|
29 | (1) |
|
Categories of Strength of Association |
|
|
30 | (1) |
|
Origin and Evolution of the Categories |
|
|
30 | (1) |
|
Sufficient Evidence of a Causal Relationship |
|
|
30 | (1) |
|
Sufficient Evidence of an Association |
|
|
31 | (1) |
|
Limited or Suggestive Evidence of an Association |
|
|
31 | (1) |
|
Inadequate or Insufficient Evidence to Determine Whether an Association Exists |
|
|
31 | (1) |
|
Limited or Suggestive Evidence of No Association |
|
|
31 | (1) |
|
|
31 | (4) |
|
Infectious Diseases Endemic to Southwest and South-Central Asia That Have Long-Term Adverse Health Outcomes |
|
|
35 | (26) |
|
|
60 | (1) |
|
Infectious Diseases Diagnosed in US Troops Who Served in the Persian Gulf War, Operation Enduring Freedom, or Operation Iraqi Freedom |
|
|
61 | (40) |
|
|
62 | (12) |
|
Enteric Infections in the Gulf War |
|
|
62 | (7) |
|
Gastroenteritis in Operation Enduring Freedom and Operation Iraqi Freedom |
|
|
69 | (5) |
|
|
74 | (4) |
|
Mild Acute Respiratory Disease in the Gulf War |
|
|
74 | (2) |
|
Severe Acute Respiratory Disease in the Gulf War |
|
|
76 | (1) |
|
Respiratory Disease in Operation Enduring Freedom and Operation Iraqi Freedom |
|
|
76 | (2) |
|
|
78 | (6) |
|
|
78 | (4) |
|
|
82 | (2) |
|
|
84 | (1) |
|
|
84 | (1) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
85 | (3) |
|
|
85 | (1) |
|
Operation Enduring Freedom and Operation Iraqi Freedom |
|
|
86 | (2) |
|
|
88 | (2) |
|
Q Fever Contracted During the Gulf War |
|
|
89 | (1) |
|
Q Fever Contracted During Operation Enduring Freedom and Operation Iraqi Freedom |
|
|
89 | (1) |
|
|
90 | (1) |
|
|
90 | (1) |
|
Department of Defense Medical Databases |
|
|
91 | (2) |
|
Department of Defense Policy Regarding Predeployment and Postdeployment Serum Collection |
|
|
93 | (1) |
|
|
94 | (7) |
|
Levels of Association Between Select Diseases and Long-Term Adverse Health Outcomes |
|
|
101 | (80) |
|
Diarrheal Diseases: Campylobacter, Non-typhoid Salmonella, and Shigella Infections |
|
|
103 | (9) |
|
|
103 | (5) |
|
Nontyphoidal Salmonella Infection |
|
|
108 | (2) |
|
|
110 | (2) |
|
|
112 | (6) |
|
Transmission and Endemicity of Brucellosis |
|
|
113 | (1) |
|
|
114 | (1) |
|
Treatments for Brucellosis and Related Long-Term Toxicity |
|
|
115 | (1) |
|
|
115 | (1) |
|
Long-Term Adverse Health Outcomes of Brucellosis |
|
|
115 | (3) |
|
|
118 | (5) |
|
Transmission of Leishmaniasis |
|
|
119 | (1) |
|
Endemicity in Southwest and South-Central Asia |
|
|
120 | (1) |
|
|
120 | (1) |
|
Diagnosis of Leishmaniasis |
|
|
121 | (1) |
|
Treatments for Leishmaniasis and Related Long-Term Toxicity |
|
|
121 | (1) |
|
Coinfection by Leishmania Parasite and Human Immunodeficiency Virus |
|
|
122 | (1) |
|
Long-Term Adverse Health Outcomes of Leishmaniasis |
|
|
122 | (1) |
|
|
123 | (6) |
|
|
124 | (1) |
|
Endemicity in Southwest and South-Central Asia |
|
|
124 | (1) |
|
|
125 | (1) |
|
Treatments for Malaria and Related Long-Term Toxicity |
|
|
125 | (1) |
|
Coinfection with Plasmodium Spp. and Human Immunodeficiency Virus |
|
|
126 | (1) |
|
Long-Term Adverse Health Outcomes of Infection with Plasmodium Spp. |
|
|
126 | (3) |
|
Q Fever (Infection by Coxiella burnetii) |
|
|
129 | (6) |
|
Transmission of Coxiella burnetii |
|
|
129 | (1) |
|
Endemicity in Southwest and South-Central Asia |
|
|
130 | (1) |
|
|
130 | (1) |
|
|
131 | (1) |
|
Coinfection with Coxiella burnetii and Human Immunodeficiency Virus |
|
|
131 | (1) |
|
Long-Term Adverse Health Outcomes of Q Fever |
|
|
132 | (3) |
|
|
135 | (14) |
|
Transmission of Tuberculosis |
|
|
135 | (2) |
|
Endemicity in Southwest and South-Central Asia |
|
|
137 | (1) |
|
Risk of Progression from Latent Tuberculosis Infection to Active Tuberculosis |
|
|
137 | (3) |
|
Treatment for Latent Tuberculosis Infection to Prevent Active Tuberculosis |
|
|
140 | (1) |
|
|
140 | (2) |
|
Late Manifestations of Active Tuberculosis |
|
|
142 | (2) |
|
Potential Relationships Between Tuberculosis and Military Service |
|
|
144 | (5) |
|
West Nile Virus Infection |
|
|
149 | (6) |
|
Transmission of West Nile Virus Infection |
|
|
150 | (1) |
|
Endemicity in Southwest and South-Central Asia |
|
|
150 | (1) |
|
|
151 | (1) |
|
Diagnosis of West Nile Fever |
|
|
151 | (1) |
|
Treatment of West Nile Virus Infection |
|
|
152 | (1) |
|
Long-Term Adverse Health Outcomes of Infection with West Nile Virus |
|
|
152 | (3) |
|
|
155 | (1) |
|
|
155 | (26) |
|
Diseases and Agents of Special Concern to Veterans of the Gulf War, Operation Iraqi Freedom, and Operation Enduring Freedom |
|
|
181 | (20) |
|
|
181 | (2) |
|
Description of Acute Illness |
|
|
182 | (1) |
|
Long-Term Adverse Health Outcomes |
|
|
182 | (1) |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
183 | (1) |
|
Idiopathic Acute Eosinophilic Pneumonia |
|
|
183 | (1) |
|
Description of Acute Illness |
|
|
183 | (1) |
|
Long-Term Adverse Health Outcomes |
|
|
183 | (1) |
|
|
184 | (1) |
|
|
184 | (1) |
|
|
184 | (1) |
|
Wound and Nosocomial Infections (Including Infections with Acinetobacter Spp.) |
|
|
184 | (6) |
|
Concerns Regarding Acinetobacter baumannii |
|
|
185 | (1) |
|
|
186 | (1) |
|
Other Nosocomial Infections |
|
|
187 | (1) |
|
Regional Experiences in Non-Americans |
|
|
188 | (2) |
|
|
190 | (1) |
|
|
190 | (3) |
|
Mycoplasmas and ``Gulf War Illness'' |
|
|
191 | (2) |
|
|
193 | (1) |
|
|
193 | (1) |
|
|
194 | (1) |
|
|
194 | (7) |
Appendix Biographical Sketches for Members of the Committee |
|
201 | (4) |
Index |
|
205 | |